2003 UW Honorary Citation Report – Lachman The 2003 Citation recipients: Dr. Holly Mason, Pamela Ploetz, Dr. Charles Sih, and Dr. Leon Lachman, with Dean Emeritus Mel Weinswig (left) and Dean Jeanette Roberts (right). Dr. Leon Lachman, PhD, ’56, earned his bachelors in pharmacy and masters in industrial pharmacy degrees from Columbia University before heading west to earn his PhD from the University of Wisconsin with a major in physical chemistry and a minor in physical-organic chemistry. His distinguished career, which spans nearly 50 years, began at CIBA Pharmaceutical Company, where he remained for 13 years, attaining the position of Director of Pharmacy Research & Development and creating a great environment for scientists to flourish. He later joined Endo Laboratories Division of DuPont, achieving the title of Vice President for Development & Control. He joined United Laboratories in Manila, Philippines in 1979 as Senior Vice President and began his consulting organization, Lachman Consultant Services, Inc., that same year. Today, Lachman Consultant Services of Westbury, New York, is one of the largest and most influential firms in the field, serving as expert technical consultants to the pharmaceutical and allied health industries. The firm helps pharmaceutical companies develop “good manufacturing practice” facilities and respond to audits by the FDA. Lachman’s scientific expertise is well demonstrated in the wide range of activities he is involved with at the firm: from bulk pharmaceutical chemical manufacture and control to FDA filings and compliance actions; to packaging and labeling operations; to validation of pharmaceutical equipment, systems, and processes. He has authored over 70 scientific publications, numerous textbooks, and holds 11 patents. Columbia University recognized his lifetime achievements awarding him an honorary Doctor of Science Degree. He has also been awarded the APhA Academy of Pharmaceutical Sciences Research Achievement Award in Pharmaceutics. Lachman distinguished himself by serving as President of the Parenteral Drug Association and as President of the Academy of Pharmaceutical Sciences. He has worked as a visiting scientist for the American Association of Colleges of Pharmacy, as Visiting Professor at the Swiss Federal Institute of Technology and Rutgers College of Pharmacy, and as an ad hoc faculty member to the FDA’s Center for Drug Evaluation and Research.